Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

Per your reading of the pre-print it seems that the RBL is still actively conducting investigations across a broad range of coronaviruses. Does this give you a strong sense of belief that a sizable grant will be given to GMU to continue with their PAN-CORONA investigation efforts as they requested in conjunction with IPIX? Who is paying now for their current efforts? Could they have received some govt funds directly that didn't require some sort of PR that would have been required if such had been granted to IPIX?

Is developing B in a inhaler form to be that severe a problem or is it pretty easy in today's world of medicine to perfect such a delivery system?

There appears to be a LOT of work to do for Brilaciidin across a wide range of possible indications as a virus killer of the first degree. Do you agree that one RBL (GMU) should handle the entire program regarding Brilacidin in this regard so it makes it quite easy to prepare further peer review articles down the line or would it be considered to make GMU the head of a broad range of investigations but farm out some of the leg work to other RBLs that may not be as busy? Or do you believe all the RBLs are taxed to the max currently on other CV efforts?

Thanks for taking the time to consider and respond on the above subjects. Having expert medical posters is such a wonderful feature for any board since most of the rest of us are medical midgets.